Results 111 to 120 of about 8,420 (193)

CD8 PET imaging with [⁸⁹Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study. [PDF]

J Immunother Cancer
Postow MA, Zang PD, Pal SK, Mauguen A, Farwell M, Gordon M, Hays D, Wong JYC, Chen D, Ulaner GA, Esposito G, McConathy J, Graham MM, Shields AF, Van den Abbeele AD, Butler MO, Thomas JS, Twardowski P, Narang J, Singh AP, Dey A, Maresca KP, Keliher E, Liu F, Potdevin G, Schmidt G, Le W, Wilson I, Mascioni A, Jia F, Korn R, Ferris MR, Schmiedehausen K, Pandit-Taskar N, Margolin KA.   +34 more
europepmc   +1 more source

[⁸⁹Zr]bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic <i>NF2</i>-related schwannomatosis: a study protocol for a phase II single centre, prospective, feasibility trial. [PDF]

BMJ Open
Douwes JPJ, Tops AL, Dibbets-Schneider P, Verbist BM, Fuentealba Bassaletti CA, Jansen JC, Koetsier KS, van Dam VS, Koot RW, van Velden FHP, Pool M, Vugts D, Schopman JE, Goeman JJ, De Geus-Oei LF, Hensen EF, Gelderblom HA.   +16 more
europepmc   +1 more source

Synthesis and Evaluation of D8W, an Octadentate Desferrioxamine Analogue with Enhanced Water Solubility Designed for ⁸⁹Zr-ImmunoPET Imaging. [PDF]

Mol Pharm
Wood JL, Ghosh S, Rosser CA, Feeney SV, Brown CJM, Fletcher NL, Wheatcroft MP, Thurecht KJ, Codd R.   +8 more
europepmc   +1 more source

Exploring the 89Zr/177Lu Theranostic Pairing with an Extracellular Matrix-Targeted Radiopharmaceutical against Triple-Negative Breast Cancer. [PDF]

Clin Cancer Res
Hachey JS, Viray TD, Carrasco SE, Carter LM, Esposito TVF, Matasci M, Ravazza D, Neri D, Lewis JS.   +8 more
europepmc   +1 more source

Radiolabeling of CHX-A″-DTPA-Antibody Conjugates with [⁸⁹Zr]ZrCl₄. [PDF]

J Nucl Med
Lyashchenko SK, Esposito TV, Tran T, Bauer D, Jones K, Park H, Carter LM, Pillarsetty NVK, Lewis JS.   +8 more
europepmc   +1 more source

Preclinical Evaluation of a Radiolabeled Anti-PSMA Dimeric Aptamer in a Murine Model of Human Prostate Cancer. [PDF]

Molecules
Sinha A, Pandya DN, Eeka P, Boyacioglu O, Gmeiner WH, Wadas TJ.   +5 more
europepmc   +1 more source

A new solid target design for the production of 89Zr and radiosynthesis of high molar activity [89Zr]Zr-DBN.

American journal of nuclear medicine and molecular imaging
Due to the advent of various biologics like antibodies, proteins, cells, viruses, and extracellular vesicles as biomarkers for disease diagnosis, progression, and as therapeutics, there exists a need to have a simple and ready to use radiolabeling synthon to enable noninvasive imaging trafficking studies.
Mukesh K, Pandey, Aditya, Bansal, Jason R, Ellinghuysen, Daniel J, Vail, Heather M, Berg, Timothy R, DeGrado   +5 more
openaire   +1 more source

Reply to "Critical Evaluation of HER2 PET Imaging in Metastatic Breast Cancer: Addressing Key Challenges and Future Directions" and "The Role of HER2 PET in Treatment of Breast Cancer". [PDF]

J Nucl Med
Yeh R.
europepmc   +1 more source

Construction and Evaluation of Guanylyl Cyclase C-Specific Antibody for Noninvasive Diagnosis and Targeted Therapy of Colorectal Cancer. [PDF]

J Nucl Med
Rong Z, Liu H, Teng X, Chen L, Gu Y, Dong B, Duan X, Wang X, Pang X.   +8 more
europepmc   +1 more source

Tetraspanin-8 as a Tumor-Selective Immuno-PET Target in Hepatocellular Carcinoma. [PDF]

J Nucl Med
Sheehan-Klenk J, Makala H, Chung JY, Lee W, Baidoo KE, Nambiar D, Alani N, Hewitt SM, Ueda Y, Omiya S, Escorcia FE.   +10 more
europepmc   +1 more source